SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C. 20549

                                FORM 8-K

                              CURRENT REPORT

                  PURSUANT TO SECTION 13 OR 15(d) OF THE
                     SECURITIES EXCHANGE ACT OF 1934

    Date of report (Date of earliest event reported): February 12, 2007

                            TECHNE CORPORATION
             (Exact Name of Registrant as Specified in Charter)


       Minnesota                     0-17272             41-1427402
(State or Other Jurisdiction       (Commission         I.R.S. Employer
of Incorporation)                  File Number)      Identification No.)

                614 Mckinley Place NE
                   Minneapolis, MN                       55413
       (Address of Principal Executive Offices)       (Zip Code)

     Registrant's telephone number, including area code:  (612) 379-8854

                              Not Applicable
      (Former Name or Former Address, if changed since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligations of the registrant under any
of the following provisions:

/ /   Written communications pursuant to Rule 425 under the Securities Act
      17 CFR 230.425)

/ /   Soliciting material pursuant to Rule 14a-12 under the Exchange Act
      (17 CFR 240.14a-12)

/ /   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240.14d-2(b))

/ /   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240.13e-4(c))






Item 5.02  Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers

Effective February 12, 2007, Dr. Karen A. Holbrook was elected to the Board of
Directors of Techne Corporation (the "Company") and to the Nominations and
governance Committee of the Board.  In connection with her service on the
Company's Board and the Nominations and Governance committee, Dr. Holbrook will
receive annual cash compensation and stock options pursuant to the Company's
director compensation policy.

Dr. Holbrook was not named as director pursuant to any arrangement or
understanding with any third person.  There is not currently, nor has there
been in the past, any transactions with the Company or any of its subsidiaries
or affiliates in which Dr. Holbrook has or had a direct or an indirect material
interest.

On February 12, 2007, the Company issued a press release announcing the
election of Dr. Holbrook to the Company's Board of Directors.  The press
release is attached as Exhibit 99.1 and is incorporated by reference herein.


Item 9.01 Financial Statements and Exhibits

     (d) Exhibits

          99.1 Press Release dated February 12, 2007.







                            SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


Dated: February 13, 2007               TECHNE CORPORATION
                                      By: /s/ Thomas E. Oland
                                      ---------------------------
                                      Name: Thomas E. Oland
                                      Title: President and Chief
                                        Executive Officer



                          EXHIBIT INDEX

    Exhibit No. Description
    ----------- -----------
       99.1     Press release of Techne Corporation dated February 12, 2007.